Nubilaria provides free EDC for pro bono COVID-19 related ARDS study
Nubilaria is providing it’s innovative ACTide EDC system free in support of a clinical study for COVID-19 related ARDS intensive
Read moreRead the latest pharmaceutical industry press releases, news updates and articles on coronavirus COVID-19 medical treatment, therapies and drug and vaccine development.
Nubilaria is providing it’s innovative ACTide EDC system free in support of a clinical study for COVID-19 related ARDS intensive
Read moreARTES Biotechnology, a Germany-based biotechnology company specialising in process development for recombinant vaccines, has commenced the development of SARS-CoV-2 vaccine
Read moreWhile COVID-19 transmission is expanding, the Japanese government has agreed to raise its Avigan® Tablet (favipiravir) stockpile, which is estimated
Read moreItalian IT and complex database consultancy Nubilaria is offering it’s cutting edge ACTide EDC web platform free of charge to
Read moreAt the end of March, the American medical devices and healthcare company Abbott Laboratories announced that the U.S. Food and
Read moreThe very first biosafety (level 4) BSL-4 laboratory in mainland China was opened in 2015, at a cost of around
Read moreWith more than 100,000 confirmed novel coronavirus cases reported across 93 countries and 3400+ deaths, a coronavirus vaccine is needed
Read moreChina, which is at the epicenter of the coronavirus (COVID-19) outbreak, is the world’s key supplier of chemical and pharmaceutical
Read moreThis week, biotechnology stocks on the verge of developing a coronavirus vaccine skyrocketed as the deadly virus sent the US
Read more